Science-concentrated cannabis company Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF), reported its third-quarter financial results Wednesday with total revenue of $13. 4 million, which is up by 7.2% from the same quarter of 2020.
Cannabis company Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF) announced Tuesday that it is selling its dispensary license, all remaining inventory and equipment at its Phoenix dispensary, in an all-cash transaction valued at $15 million.
Science-focused cannabis company and IP developer Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF) announced Friday that its Vireo Health of New York subsidiary is launching whole flower cannabis products at three of its four New York dispensaries.
Cannabis company Goodness Growth Holdings, Inc. (CSE: GDNS; OTCQX: GDNSF) announced Tuesday the closing of a sale leaseback transaction in New York with marijuana-oriented real estate investment trust Innovative Industrial Properties, Inc. (NYSE:
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF
On Thursday, AdvisorShares launched the country’s first actively managed ETF covering the psychedelics sector.
Resurgent Biosciences, a subsidiary of Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF), is launching a survey study that will look into the varying effects of entheogen and psychedelic experiences for therapeutic, religious and spiritual purposes.